Kilitch Drugs is locked at upper circuit at Rs. 48.70, up by 8.10 points or 19.95% from its previous closing of Rs. 40.60 on the BSE.
The scrip opened at Rs. 43.95 and has touched a high and low of Rs. 48.70 and Rs. 43.20 respectively. So far 2,67,277 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 61.00 on 06-Jan-2016 and a 52 week low of Rs. 30.85 on 24-Jun-2016.
Last one week high and low of the scrip stood at Rs. 48.70 and Rs. 33.20 respectively. The current market cap of the company is Rs. 64.44 crore.
The promoters holding in the company stood at 64.50%, while Institutions and Non-Institutions held 0.01% and 35.49% respectively.
Kilitch Drugs (India) has been allotted land admeasuring 4317.5 square meters in Oromia Special Zone in Ethiopia. The company’s subsidiary Kilitch Estro Biotech PLC has been allotted the land on a lease for a period of forty five years by the Bureau of Rural Land and Environmental Protection, Federal Democratic Republic of Ethiopia.
The said land is strategically located and touches the highway with three phase electricity passing through the land itself. The size of the said land allotted is big enough so as to set up a fully integrated pharma plant therein at any time in future.
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1830.20 |
Dr. Reddys Lab | 1183.00 |
Cipla | 1549.65 |
Lupin | 2094.65 |
Zydus Lifesciences | 887.70 |
View more.. |